The Legislation combines spending and policy priorities from 11 congressional committees and will reshape federal policy across nearly every sector ...

The drug industry’s top lobbying group is appealing its latest loss in its challenge to Medicare’s Drug Price Negotiation Program to the Fifth Circuit, returning the case to an appeals court that has ...

A federal appeals panel voted 2-to-1 against a group of international aid groups, ruling they did not have the legal standing to bring a lawsuit. Meanwhile, the Trump administration has ordered a ...

Drug companies have formed a new group to present lawmakers with research on what the industry sees as the negative impacts ...

Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, ...

New Medicare changes are here, offering major cost savings for retirees. Learn about 8 expenses you may no longer have to pay, from insulin to drug costs.

Hospital and health system groups are skeptical the Trump administration will have enough time to weigh and incorporate ...

Trump vows to slash drug prices and boost U.S. manufacturing, but tariffs and market realities may drive costs higher instead ...

From rethinking launch price logic to implementing rebate-aware modeling and patient-first access programs, this installment ...

The Inflation Reduction Act (IRA) authorized the federal government to force prescription drug manufacturers to "negotiate" drug prices for ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Pharma industry loses on Medicare price ...